About The Study: The Medicare $35 insulin out-of-pocket cap implemented in 2023 decreased and stabilized insulin out-of-pocket cost, increasing insulin use for people with previously high out-of-pocket cost. These findings can inform the design of policies to boost insulin access among users with high out-of-pocket cost.
Corresponding Author: To contact the corresponding author, Rebecca Myerson, PhD, email Rebecca.myerson@emory.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2026.5975)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: This study is being presented at the 2026 American Diabetes Association’s Scientific Sessions.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.5975?guestAccessKey=0c80bdb6-595e-45b1-97bd-c5a714f0c368&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060626
Journal
JAMA